, Singapore

Here's the only good news in Singapore's dismal industrial production

It fell 2.4% excluding biomed output.

According to Nomura, industrial production surprised markets on the upside increasing by 2.1% y-o-y in May, albeit down from an upwardly revised 5.0% y-o-y in April (Consensus: 0.1%; Nomura: -0.9%). The key driver remained biomedical output, which rose by 22.8% y-o-y from 41.9% in April.

Nomura said that excluding this, IP fell by 2.4% y-o-y, following a drop of 2.7% in April. That said, there were still some encouraging signs as IP growth on a sequential (month-on-month, seasonally adjusted) basis remained in positive territory (1.3% in May from 3.6% in April). In addition, electronics output rose for a second straight month, by 4.3% y-o-y in May from 1.6% in April.

"This however remains at odds with electronics exports, which are still contracting (-13.2% y-o-y in May from -9.0% in April)," Nomura said.

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.